Differentiating Between Autologous & Allogeneic Clinical Regulation to Spotlight Allogeneic Therapies
Time: 3:30 pm
day: Conference Day One
Details:
- Comparing regulatory requirements for allogeneic versus autologous therapies to highlight the key differences
- Examining the use of platform technology in starting materials, donor screening, and selection for allogeneic therapies
- Delving into the manufacturing process of allogeneic therapies and how this is impacted by policy
